Eaton Vance Management
- SEC CIK
- 0001076598
- Latest filing
- Nov 14, 2022
DNLI holding history
Denali Therapeutics Inc. in every 13F filed by Eaton Vance Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNLI overviewAll 13F holders of DNLIFull Q3 2022 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q1 2022